775PN42SDL PN 7.75% 2042NSE
Windlas Biotech is among the top five players in the domestic pharmaceutical formulations CDMO (Contract Development and Manufacturing Organization) industry in terms of revenue.Don't have a Tradeplus account? Sign up
|Date||04Aug2021 - 06Aug2021|
|Price Range (₹)||448 – 460|
|Minimum Order Quantity||30|
The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing, and commercial manufacturing of generic products. In addition to providing services and products in the CDMO market, the company also sells its products in the trade generics and OTC markets as well as export generic products to several countries. Read more
|Financial Year Ended||Revenue (₹ Millions)||Profit After Tax (₹ Millions)||EPS (₹)|
You can apply for the Windlas Biotech IPO IPO using any supported UPI app by following two steps:
On acceptance of the mandate, the bid amount will get blocked in your bank account.
Have Questions? Chat with us through whatsapp!
Powered by Tradeplus
I'm a cool paragraph that lives inside of an even cooler modal. Wins!
You will receive an OTP on your mobile